Dubbing down translation: The functional interaction of deubiquitinases with the translational machinery

8Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Cancer cells revamp the regulatory processes that control translation to induce tumor-specific translational programs that can adapt to a hostile microenvironment as well as withstand anticancer therapeutics. Translational initiation has been established as a common downstream effector of numerous deregulated signaling pathways that together culminate in prooncogenic expression. Other mechanisms, including ribosomal stalling and stress granule assembly, also appear to be rewired in the malignant phenotype. Therefore, better understanding of the underlying perturbations driving oncogenic translation in the transformed state will provide innovative therapeutic opportunities. This review highlights deubiquitinating enzymes that are activated/dysregulated in hematologic malignancies, thereby altering the translational output and contributing to tumorigenesis.

Cite

CITATION STYLE

APA

Kapadia, B. B., & Gartenhaus, R. B. (2019). Dubbing down translation: The functional interaction of deubiquitinases with the translational machinery. Molecular Cancer Therapeutics. American Association for Cancer Research Inc. https://doi.org/10.1158/1535-7163.MCT-19-0307

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free